News - Pharmaceuticals
PBAC decision looms for tumour-agnostic immunotherapy funding
After eight years of debate involving industry, clinicians, and patient advocacy groups, hope may be on the horizon for a […]
MoreNews - MedTech & Diagnostics
CEO transition at Device Technologies signals next chapter as sale looms
Heath Priestly has been appointed CEO of Device Technologies, following his role as Managing Director for Australia & New Zealand […]
MoreNews - Biotechnology
Cell and gene sector gains national voice with new advisory group
AusBiotech and Medicines Australia are inviting expressions of interest from current members to join the newly established Advanced Therapies Advisory […]
MoreDigital & Innovation
Virtual cardiac rehab cuts hospital readmission days by 70%
A virtual cardiac rehabilitation program is showing significant promise in reshaping chronic disease management, with a new evaluation revealing it […]
MoreLeadership & Management
Leadership homecoming at Vertex ANZ: New country head returns to chart future growth
Vertex Pharmaceuticals has appointed Elisha Whitfield as Senior Country Manager for Australia and New Zealand, effective 1 December 2025. For […]
MoreESG
First climate risk report delivers dire warning: Will policy catch up?
The federal government’s release of the inaugural National Climate Risk Assessment highlights the serious impacts of climate change on human […]
MoreHuman Resources
Merck, Edwards Lifesciences, Daiichi Sankyo and Telix crowned Excellence Awardees: Australian HR Awards
Merck, Edwards Lifesciences, Daiichi Sankyo, and Telix Pharmaceuticals have emerged as Excellence Awardees at the Australian HR Awards, highlighting their […]
MoreMedical and Science
MRFF billions locked away by government as research institutions struggle
New costings from the Parliamentary Budget Office (PBO) have revealed that the annual Medical Research Future Fund (MRFF) funding could […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreLatest News in Pharma, MedTech, Diagnostics & Biotech
Leadership homecoming at Vertex ANZ: New country head returns to chart future growth
October 3, 2025
in Leadership & Management
CEO transition at Device Technologies signals next chapter as sale looms
October 3, 2025
in News - MedTech & Diagnostics
PBAC decision looms for tumour-agnostic immunotherapy funding
October 3, 2025
in News - Pharmaceuticals
HTA review implementation: Mapping progress or just more delays?
October 1, 2025
in News - Pharmaceuticals
Abbott pushes for device-specific funding in tricuspid regurgitation
October 1, 2025
in News - MedTech & Diagnostics
Sandoz biosimilar sparks uptake and savings debate
October 1, 2025
in News - Pharmaceuticals
Calls grow to lift the curtain on outdated breast cancer screening program
October 1, 2025
in News - MedTech & Diagnostics
Cell and gene sector gains national voice with new advisory group
October 1, 2025
in News - Biotechnology
Collingwood takes the helm at Stryker South Pacific as Ben-Mayor closes a two-decade legacy
September 29, 2025
in Leadership & Management
World Heart Day sparks call for a ‘real shift’ in priorities and mindset, say Advara Heartcare and Heart Support Australia leaders
September 29, 2025
in News - MedTech & Diagnostics
HTA failure forces more pharma companies to pull innovative therapies from Australian market
September 29, 2025
in News - Pharmaceuticals
AstraZeneca’s first-in-class therapy PBS listed in advanced breast cancer
September 29, 2025
in News - Pharmaceuticals
Lp(a): Bad cholesterol’s evil cousin driving hidden cardiovascular risk
September 29, 2025
in News - Pharmaceuticals
New PBS listings to expand access in rare disease, ophthalmology and women’s health
September 29, 2025
in News - Pharmaceuticals
MRFF billions locked away by government as research institutions struggle
September 29, 2025
in Medical and Science
Policymakers ‘dragging the anchor’ leaves Alzheimer’s patients stranded at the edge of hope
September 26, 2025
in News - Pharmaceuticals
IBD experts forge their own path as policymakers fail to deliver
September 26, 2025
in News - Pharmaceuticals
A national first: Private hospital funding linked to patient-reported outcomes
September 26, 2025
in News - MedTech & Diagnostics
Rearranging the deckchairs won’t cut it: Lived experience must drive health policy decisions
September 26, 2025
in News - Pharmaceuticals
Follow Us
Partner with us
Leadership & Management
Leadership homecoming at Vertex ANZ: New country head returns to chart future growth
Vertex Pharmaceuticals has appointed Elisha Whitfield as Senior Country Manager for Australia and New Zealand, effective 1 December 2025. For […]
MoreNews - MedTech & Diagnostics
CEO transition at Device Technologies signals next chapter as sale looms
Heath Priestly has been appointed CEO of Device Technologies, following his role as Managing Director for Australia & New Zealand […]
MoreNews - Pharmaceuticals
PBAC decision looms for tumour-agnostic immunotherapy funding
After eight years of debate involving industry, clinicians, and patient advocacy groups, hope may be on the horizon for a […]
MoreNews - Pharmaceuticals
HTA review implementation: Mapping progress or just more delays?
The Health Technology Assessment (HTA) Review Implementation Advisory Group (the IAG) is developing its advice on a draft implementation roadmap […]
More